Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 150 | 0 | N/A | 0 | 0 |
| TOTAL | $180 | $0 | $N/A | $0 | $0 |
| Non-Current Assets | |||||
| Intangibles | 7 | 0 | 0 | 0 | 0 |
| TOTAL | $7 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $187 | $0 | $N/A | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 539 | 0 | N/A | 0 | 0 |
| Accounts payable and accrued liabilities | 482 | 0 | 0 | 0 | 0 |
| Other current liabilities | 1 | 0 | N/A | 0 | 0 |
| TOTAL | $1,481 | $0 | $N/A | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,481 | $0 | $N/A | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10 | N/A | N/A | N/A | N/A |
| Common Shares | 4 | 0 | N/A | 0 | 0 |
| Retained earnings | -2,575 | 0 | N/A | 0 | 0 |
| TOTAL | $-1,294 | $0 | $N/A | $0 | $0 |
| Total Liabilities And Equity | $187 | $0 | $0 | $0 | $0 |